Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mike, Alley"'
Autor:
Gregoire Prevost, Pierre Roubert, Daniel W. Zaharevitz, Marie Odile Lonchampt, Samir Attoub, Sophie Chaumeron, Mike Alley, Erik Bruyneel, Hélène Coulomb, Ann Savola, Philip G. Kasprzyk, Susan Holbeck, John Wright, Quang-Dé Nguyen, Patricia Forgez, Christian Gespach, Marie C. Brezak, Mark Bracke, Eric Ferrandis, Marion Huchet, Danièle Demarquay
Publikováno v:
Cancer Research. 66:9227-9234
A large number of hormones and local agonists activating guanine-binding protein-coupled receptors (GPCR) play a major role in cancer progression. Here, we characterize the new imidazo-pyrazine derivative BIM-46174, which acts as a selective inhibito
Autor:
Susan D. Mertins, John E. Niederhuber, Meghan Gowens, Dominic A. Scudiero, Christina H. Stuelten, Karen M. Hite, Robert H. Shoemaker, Melinda G. Hollingshead, Mike Alley, Johanna I. Busch, Mark W. Burkett
Publikováno v:
Stem Cells
Tumor stem cells or cancer initiating cells (CICs) are single tumor cells that can regenerate a tumor or a metastasis. The identification and isolation of CICs remain challenging, and a variety of putative CIC markers have been described. We hypothes
Autor:
Mike Alley, David G. Covell, Gabriela Tudor, Christopher M Nelson, Edward A. Sausville, Peter L. Gutierrez, Ruili Huang
Publikováno v:
Anti-cancer drugs. 16(4)
The elevated expression of the flavoprotein NAD(P)H:quinone acceptor oxidoreductase (NQO1) (EC 1.6.99.2) in many human solid tumors, along with its ability to activate quinone-based anticancer agents, makes it an excellent target for enzyme-directed
Autor:
Gabriela Tudor, Mike Alley, Christopher M Nelson, Ruili Huang, David G Covell, Peter Gutierrez, Edward A Sausville
Publikováno v:
Anti-Cancer Drugs; Apr2005, Vol. 16 Issue 4, p381-391, 11p